FRASCERRA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 662
EU - Europa 244
AS - Asia 97
AF - Africa 16
OC - Oceania 2
SA - Sud America 1
Totale 1.022
Nazione #
US - Stati Uniti d'America 654
IT - Italia 106
SE - Svezia 44
BG - Bulgaria 38
CN - Cina 36
VN - Vietnam 28
GB - Regno Unito 25
SG - Singapore 17
DE - Germania 11
CI - Costa d'Avorio 9
CA - Canada 8
FR - Francia 6
IN - India 6
FI - Finlandia 5
HK - Hong Kong 5
PL - Polonia 4
SN - Senegal 4
NG - Nigeria 3
TR - Turchia 3
AU - Australia 2
AE - Emirati Arabi Uniti 1
KR - Corea 1
LT - Lituania 1
NO - Norvegia 1
PE - Perù 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 1.022
Città #
Houston 91
Fairfield 89
Woodbridge 82
Chandler 67
Seattle 43
Milan 40
Sofia 38
Wilmington 38
Cambridge 34
Ann Arbor 28
Ashburn 28
Beijing 27
New York 24
Serra 22
Princeton 21
Lawrence 16
London 15
Dong Ket 11
Medford 10
Abidjan 9
Florence 7
Frankfurt am Main 6
Ottawa 6
Dakar 4
Des Moines 4
Hong Kong 4
Nanjing 4
Redwood City 4
Rome 4
San Diego 4
Lagos 3
Los Angeles 3
Pietrasanta 3
Warsaw 3
Bremen 2
Gainesville 2
Gavorrano 2
Jiaxing 2
Newcastle upon Tyne 2
Norwalk 2
Parma 2
Reggio Calabria 2
San Francisco 2
Sartell 2
Toronto 2
Adelaide 1
Bratislava 1
Bristol 1
Canosa Di Puglia 1
Central 1
Changsha 1
Chicago 1
Empoli 1
Hebei 1
Indiana 1
Islington 1
Istanbul 1
Kilburn 1
Lancaster 1
Lima 1
Lowell 1
Mersin 1
Oslo 1
Phoenix 1
Pisa 1
Polska 1
San Casciano in Val di Pesa 1
Shenyang 1
Sydney 1
Vicenza 1
Totale 839
Nome #
Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in nondiabetic, morbidly obese patients 137
null 107
null 105
Intestinal glucose absorption is a key determinant of 1-hour postload plasma glucose levels in nondiabetic subjects 90
null 88
A mixed nutrient preload attenuates glucose-induced endothelial dysfunction in individuals with abnormal glucose tolerance 70
The insulinotropic effect of a high-protein nutrient preload is mediated by the increase of plasma amino acids in type 2 diabetes 61
Comparison of paracetamol absorption and gastric emptying measured by scintigraphy in relation to rate of appearance of oral glucose and postprandial glycaemia 55
Effect of Roux-En-Y gastric bypass on beta cell function and glucose metabolism in type 2 diabetic and non-diabetic patients 53
A Protein/Lipid Preload Attenuates Glucose-Induced Endothelial Dysfunction in Individuals with Abnormal Glucose Tolerance 49
Sustained Effects of a Protein and Lipid Preload on Glucose Tolerance in Type 2 Diabetes 45
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial 44
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821 35
Effects of a small protein and lipid preload on oral glucose tolerance in subjects with normal and impaired glucose tolerance 29
Effects of sustained treatment with lixisenatide on gastric emptying and glucose metabolism in type 2 diabetes 29
Abnormal Glucose Tolerance Is Associated with a Reduced Myocardial Metabolic Flexibility in Patients with Dilated Cardiomyopathy 27
Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals 23
Sustained effects of a protein and lipid preload on glucose tolerance in type 2 diabetes patients 15
Mechanisms through which a small protein and lipid preload improves glucose tolerance 12
Totale 1.074
Categoria #
all - tutte 3.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 0 0 0 0 0 0 0 0 19 19
2019/2020189 13 8 2 4 9 22 17 38 23 16 25 12
2020/2021183 6 25 18 24 22 12 4 6 15 14 6 31
2021/2022157 8 3 5 11 27 26 1 5 9 3 10 49
2022/2023199 23 44 28 4 14 25 0 11 34 1 15 0
2023/2024125 19 20 27 11 15 25 5 1 0 2 0 0
Totale 1.074